Despite an unexpected slowdown in U.S. procedure growth, system placements remained healthy, and the surgical robotics company maintained its 2026 forecast for worldwide da Vinci robot procedures.
Source: MedTech Dive
You may also like
Trump’s CDC Nominee Praises Vaccines, Without Vowing...
Watch: ‘Robust’ Primary Care, Transparency Top...
Insurers Hedge on Trump-Backed Pledge To Improve...
Large funding rounds help boost digital health...
Medtronic completes SPR Therapeutics acquisition
Doc pay, price transparency on Congress’ healthcare...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.